ChemicalBook > CAS DataBase List > Octreotide acetate

Octreotide acetate

Product Name
Octreotide acetate
CAS No.
83150-76-9
Chemical Name
Octreotide acetate
Synonyms
ctreotide;DARAMONOL;GMP(CFDA);OXTREOTIDE;Longastatin;Octreotide acetate;Octreotode Acetate;Ocetreotide, Acetate;Octreotide oral film;Octreotide Acetate(b)
CBNumber
CB2138033
Molecular Formula
C49H66N10O10S2
Formula Weight
1019.24
MOL File
83150-76-9.mol
More
Less

Octreotide acetate Property

Melting point:
>140°C (dec.)
Boiling point:
1447.2±65.0 °C(Predicted)
Density 
1.39±0.1 g/cm3(Predicted)
storage temp. 
-20°C
solubility 
Soluble in acetic acid, DMSO, and methanol
pka
12.60±0.70(Predicted)
form 
Solid
color 
White to Off-White
Water Solubility 
Soluble to 1.20 mg/ml in water
Stability:
Hygroscopic
InChIKey
DEQANNDTNATYII-MEUDYGGUSA-N
CAS DataBase Reference
83150-76-9
More
Less

Safety

WGK Germany 
3
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
O1014
Product name
Octreotide
Purity
≥98% (HPLC)
Packaging
1mg
Price
$249.6
Updated
2024/03/01
Sigma-Aldrich
Product number
O1014
Product name
Octreotide
Purity
≥98%(HPLC)
Packaging
500μg
Price
$297
Updated
2024/03/01
Sigma-Aldrich
Product number
Y0002106
Product name
Octreotide impurity mixture
Purity
CRS, European Pharmacopoeia (EP) Reference Standard
Packaging
Y0002106
Price
$154
Updated
2023/06/20
Sigma-Aldrich
Product number
1477604
Product name
Octreotide acetate
Purity
United States Pharmacopeia (USP) Reference Standard
Packaging
4.37mg
Price
$1300
Updated
2021/12/16
Usbiological
Product number
256093
Product name
Octreotide Acetate
Packaging
1mg
Price
$319
Updated
2021/12/16
More
Less

Octreotide acetate Chemical Properties,Usage,Production

Description

Octreotide is a long-acting somatostatin analog indicated for symptomatic control in acromegaly and gastroenteropancreatic tumors. Other potential uses under investigation include diabetes, psoriasis and Alzheimer's disease.

Originator

Sandoz (Switzerland)

Uses

Octreotide Acetate is the acetate salt of a synthetic long-acting cyclic octapeptide with pharmacologic properties mimicking those of the natural hormone somatostatin. It inhibits the secretion of growth hormone, glucagon, insulin, gastrin, vasoactive intestinal peptide, secretin, motilin and pancreatic polypeptide. Octreotide acetate was uses for the treatment of severe diarrhea and flushing associated with malignant carcinoid tumors, acromegaly, and diarrhea associated with VIPoma; and, then in 2010, for the treatment of neuroendocrine tumors.

Indications

Octreotide acetate (Sandostatin) is a synthetic peptide analogue of the hormone somatostatin. Its actions include inhibition of the pituitary secretion of growth hormone and an inhibition of pancreatic islet cell secretion of insulin and glucagon. Unlike somatostatin, which has a plasma half-life of a few minutes, octreotide has a plasma elimination half-life of 1 to 2 hours. Excretion of the drug is primarily renal.

brand name

Sandostatin (Novartis).

Therapeutic Function

Antiulcer, Growth hormone inhibitor

Biological Functions

Octreotide acetate, a long-acting octapeptide analogue of somatostatin, has a half-life of approximately 100 minutes. A comparison of the primary structures of octreotide and somatostatin suggests little similarity, but from earlier work at the Salk Institute it was known that not all the residues in somatostatin were necessary to elicit its full biological activity. Other studies suggested that the essential fragment for its activity was the tetrapeptide Phe7-Trp8- Lys9-Thr10. These earlier studies helped in the design of the potent drug now known as octreotide acetate. This drug suppresses the secretion of gastroenteropancreatic peptides, such as gastrin, vasoactive intestinal peptide (VIP), insulin, and glucagon, as well as pituitary GH. Furthermore, it is more potent than natural somatostatin in inhibiting the release of glucagon, insulin, and GH.

General Description

Octreotide is a somatostatin analogue with D-Phe-Cys-Phe-D-Trp-Lys-ThrCys-Thr-OH amino acid sequence.

Biochem/physiol Actions

Octreotide is three times more potent than the native hormone in inhibiting the secretion of growth hormone glucagon and insulin in vivo. Octreotide regulates serum prolactin levels and resolves galactorrhea or (secondary) amenorrhea in acromegaly patients. Hence, this peptide can be considered as a potent therapeutic for acromegaly treatment.

Clinical Use

Octreotide acetate(83150-76-9) is used by SC injection in the palliative treatment of patients with metastatic carcinoid tumors, which are tumors of the endocrine system, GI tract, and lung (gastroenteropancreatic). Carcinoid tumors secrete increasing amounts of vasoactive substances, including histamine, serotonin, bradykinin, and prostaglandins. Octreotide acetate inhibits or suppresses the release of these vasoactive substances and, thus, is useful in treating the severe diarrhea, facial flushing, and wheezing episodes that accompany carcinoid tumors. In addition, it finds use in the palliative management of VIP-secreting tumors (VIPomas, usually pancreatic tumors). Patients with VIPomas suffer a profuse, watery diarrhea syndrome, and octreotide acetate is able to help by decreasing the release of damaging intestinal tumor cell secretions. Octreotide also helps to reduce hypokalemia by correcting electrolyte imbalances.
An excessive secretion of GH from the pituitary can cause the disorder known as acromegaly, which is characterized by a progressive enlargement of the head, face, hands, feet, and thorax. Inasmuch as octreotide acetate is able to decrease the secretion of GH from the pituitary, it is used in treating patients with acromegaly who are unresponsive to previous pituitary radiation therapy or surgery. It is used in the treatment of acromegaly, because it reduces the blood levels of both GH and insulin-like growth factor-I (IGF-I). The long-acting repository form of octreotide acetate also is used in treating acromegaly, carcinoid tumors, and VIPomas, but in monthly depot injections.
Octreotide for IV injection is used in the treatment of acute bleeding from esophageal varices. Variceal bleeding occurs in about half the patients with cirrhosis of the liver and is responsible for about one-third of deaths in these patients. Octreotide is a potent vasoconstrictor that reduces portal and collateral blood flow by constricting visceral vessels, which leads to reduced portal blood pressure and decreases the bleeding.

Side effects

Some common side effects of octreotide acetate include cardiac conduction disorder, gallbladder sludge, hyperglycemia, cardiac arrhythmia, and hypoglycemia.
Octreotide acetate may cause serious side effects, and if any of these occur, you should contact your doctor immediately. These side effects include signs of gallstones, high blood sugar, low blood sugar, and underactive thyroid. Signs of gallstones include fever, chills, nausea, vomiting, severe pain in your upper stomach spreading to your back, dark urine, clay-colored stools, or yellowing of the skin or eyes. Signs of high blood sugar include increased thirst, increased urination, dry mouth, and fruity breath odor. Signs of low blood sugar include headache, hunger, sweating, irritability, dizziness, fast heart rate, and feeling anxious or shaky. Signs of underactive thyroid include extreme tiredness, dry skin, joint pain or stiffness, muscle pain or weakness, hoarse voice, feeling more sensitive to cold temperatures, and weight gain.
https://www.drugs.com/sfx/octreotide-side-effects.html

Veterinary Drugs and Treatments

Octreotide may be useful in the adjunctive treatment of hyperinsulinemia in patients with insulinomas (especially dogs, ferrets). Response is variable, presumably dependent on whether the tumor cells have receptors for somatostatin. Octreotide may also be useful in the diagnosis and symptomatic treatment of gastrinomas in dogs or cats. It may be of use in the treatment of acute pancreatitis, but more research is needed before it can be recommended for this use in veterinary patients.

storage

Desiccate at -20°C

Mode of action

Octreotide acetate is a synthetic somatostatin analogue with similar pharmacologic effects to naturally occurring somatostatin, but with a prolonged duration of action. It inhibits pathologically increased secretion of growth hormone, thyroid stimulating hormone, and serotonin, insulin, glucagon, and other peptides produced within the gastro-entero-pancreatic endocrine system. Somatostatin is cell cycle phase-specific, mediating arrest at the G1- phase. Long acting somatostatin analogues have been shown to inhibit tumour growth.

Octreotide acetate Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Octreotide acetate Suppliers

Hangzhou Peptidego Biotech Co.,Ltd.
Tel
0571-87213919
Fax
0571-87213919
Email
Eric@peptidego.com
Country
China
ProdList
6756
Advantage
58
Hangzhou nuotong biotechnology co. LTD
Tel
0571-88589737 15268405618
Email
sisi.xiang@sinopep.com
Country
China
ProdList
87
Advantage
58
Phygene
Tel
18059081430
Email
2070812664@qq.com
Country
China
ProdList
1232
Advantage
58
Suzhou Tianma Pharma Group Tianji Bio-Pharmaceutical Co., Ltd.
Tel
0512-68322275 15850786624
Email
danielzhao@tianmapharma.com
Country
China
ProdList
30
Advantage
58
Sichuan Takele Biotechnology Co., Ltd.
Tel
+86-028-64348587 15680781153
Email
sales@takelepeptide.com
Country
China
ProdList
86
Advantage
58
INTATRADE GmbH
Tel
+49 3493/605464
Fax
+49 3493/605470
Email
sales@intatrade.de
Country
Germany
ProdList
3572
Advantage
66
Chembest Research Laboratories Limited
Tel
+86-21-20908456
Fax
021-58180499
Email
sales@BioChemBest.com
Country
China
ProdList
6005
Advantage
61
GL Biochem (Shanghai) Ltd
Tel
21-61263452 13641803416
Fax
86-21-61263399
Email
ymbetter@glbiochem.com
Country
China
ProdList
9981
Advantage
64
LGM Pharma
Tel
1-(800)-881-8210
Fax
615-250-9817
Email
inquiries@lgmpharma.com
Country
United States
ProdList
2123
Advantage
70
Shanghai Hanhong Scientific Co.,Ltd.
Tel
021-54306202 13764082696
Email
info@hanhongsci.com
Country
China
ProdList
42958
Advantage
64
More
Less

View Lastest Price from Octreotide acetate manufacturers

Sinoway Industrial co., ltd.
Product
Octreotide Acetate 83150-76-9
Price
US $0.00/Kg/Bag
Min. Order
2Kg/Bag
Purity
High Density
Supply Ability
20 tons
Release date
2021-07-13
HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
Product
Octreotide acetate 83150-76-9
Price
US $100.00-75.00/kg
Min. Order
1kg
Purity
99%
Supply Ability
5000Ton
Release date
2024-08-12
WUHAN FORTUNA CHEMICAL CO., LTD
Product
Octreotide acetate 83150-76-9
Price
US $0.00-0.00/KG
Min. Order
1g
Purity
98%min
Supply Ability
1 KG
Release date
2021-06-03

83150-76-9, Octreotide acetateRelated Search:


  • DARAMONOL
  • ctreotide
  • Ocetreotide, Acetate
  • L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl-, cyclic (2?7)-disulfide
  • OXTREOTIDE
  • [R-(R*,R*)]-D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[2-hydroxy-1-(hydroxy-methyl)propyl]-cysteinamide cyclic(2->7)-disulfide
  • Octreotide acetate
  • L-cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-(2-hydroxy-1-(hydroxymethyl) propyl)-cyclic (2->7)-disulfide, (R-(R*,R*))
  • H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-L-threoninol acetate salt (Disulfide bond)
  • [R-(R^<*>^,R^<*>^)]-D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[2-hydroxyl-1-(hydroxyl-methyl)propyl]-L-cysteinarnide cydic(2→7)-disulfide
  • Longastatin
  • D-Phe-Cys(1)-Phe-D-Trp-Lys-Thr-Cys(1)-N-[(1R,2R)-1-(Hydroxymethyl)-2-hydroxypropyl]-NH2
  • D-Phe-L-Cys(1)-L-Phe-D-Trp-L-Lys-L-Thr-L-Cys(1)-N-[(1R,2R)-2-Hydroxy-1-(hydroxymethyl)propyl]-NH2
  • Octreotode Acetate
  • OCTREOTIDE ACETATE (GMP)
  • APIOC OCTREOTIDE ACETATE
  • Octreotide Hydrochloride
  • (4R,7S,10S,13R,16S,19R)-13-((1H-Indol-3-yl)methyl)-19-((R)-2-amino-3-phenylpropanamido)-10-(4-
  • GMP(CFDA)
  • 32) Octreotide Acetate
  • Octreotide acetate USP/EP/BP
  • Octreotide Acetate(b)
  • Octreotide oral film
  • 83150-76-9
  • C49H66N10O10S22C2H4O
  • C48H66N10O9S2
  • C49H66N10O10S22C2H4O2
  • 101924
  • Inhibitors
  • API
  • Peptide